Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas
14 مناظر
• 07/18/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Jonathan C. Trent, MD, professor of Medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses the FDA approval of trabectedin for patients with soft tissue sarcomas.
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے